Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Elicio Therapeutics, Inc. | Director, 10%+ Owner | Convertible Note (convertible into Common Stock) | 3.44M | $20M | $5.81 | Aug 12, 2024 | Held by GKCC, LLC |
Elicio Therapeutics, Inc. | Director, 10%+ Owner | Pre-Funded Warrants | 1.6M | $7.98M | $4.99 | Jun 28, 2024 | Direct |
Immix Biopharma, Inc. | Director, 10%+ Owner | Common Stock | 3.24M | $6.9M | $2.13 | Jun 11, 2024 | Held by GKCC, LLC |
Elicio Therapeutics, Inc. | Director, 10%+ Owner | Pre-Funded Common Stock Purchase Warrant | 1.03M | $6M | $5.81 | Mar 19, 2024 | Held by GKCC, LLC |
Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 7M | $5.32M | $0.76 | Jun 7, 2024 | Held by GKCC, LLC |
Elicio Therapeutics, Inc. | Director, 10%+ Owner | Common Warrants | 1.6M | Jun 28, 2024 | Direct | ||
Immix Biopharma, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 33K | Jun 11, 2024 | Direct | ||
Elicio Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 4.1K | Nov 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELTX | Elicio Therapeutics, Inc. | Nov 21, 2024 | 1 | $0 | 4 | Nov 25, 2024 | Director, 10%+ Owner |
ELTX | Elicio Therapeutics, Inc. | Aug 12, 2024 | 1 | $20M | 4 | Aug 14, 2024 | Director, 10%+ Owner |
ELTX | Elicio Therapeutics, Inc. | Jun 28, 2024 | 2 | $7.98M | 4 | Jul 2, 2024 | Director, 10%+ Owner |
IMMX | Immix Biopharma, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director, 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Jun 7, 2024 | 0 | $0 | 3 | Sep 27, 2024 | 10%+ Owner |
ELTX | Elicio Therapeutics, Inc. | Mar 19, 2024 | 1 | $6M | 4 | Mar 20, 2024 | Director, 10%+ Owner |
ELTX | Elicio Therapeutics, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Director, 10%+ Owner |
ELTX | Elicio Therapeutics, Inc. | Dec 22, 2023 | 1 | $7.05M | 4 | Dec 26, 2023 | Director, 10%+ Owner |
IMMX | Immix Biopharma, Inc. | Aug 22, 2023 | 2 | $0 | 4 | Aug 23, 2023 | Director, 10%+ Owner |
IMMX | Immix Biopharma, Inc. | Aug 22, 2023 | 0 | $0 | 3 | Aug 23, 2023 | Director, 10%+ Owner |
ELTX | Elicio Therapeutics, Inc. | Jun 1, 2023 | 0 | $0 | 3 | Jun 12, 2023 | Director |